clinical trial spotlight: alchemist for early-stage alk and egfr lung cancer patients
Published 8 years ago • 176 plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
4:20
clinical trial spotlight: determining efficacy of immunotherapy in stage iii lung cancer
-
12:58
egfr inhibitor therapy in second line
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
12:04
currently enrolling clinical trials of single agent immunotherapies for patients with lung cancer
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
5:05
the alchemist trial for egfr mutation-positive patients - an overview
-
10:02
gracecast-137_ca-101-_dr. ramalingam: q and a session on clinical trials in oncology
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
2:05
first line egfr based therapy for advanced squamous non small cell lung cancer nsclc
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
17:30
gracecast-084_lung-cancer_alk inhibition: science and early clinical experience by dr. ben solomon
-
14:59
gracecast-074_lung-cancer_ccilc - adjuvant therapy for smaller node-negative nsclc
-
6:26
the adaura trial: the effect on egfr treatment
-
3:35
grace targeted therapies lung cancer 2021 - current treatment options for egfr fusions e.g. rad 51
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023